Search

everythinglearnresearchcommunity

for

Search:↓

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Early hair greying may increase the risk of heart disease.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

H. pylori infection may be linked to insulin resistance in women with PCOS.

Higher SFRP-4 levels were found in people without a diabetic family history.

A cat with skin bumps and itching had high blood fats and skin infections, which improved with diet and medication changes.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Metformin may improve acanthosis nigricans by reducing insulin resistance.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Intermittent fasting improves metabolism and reduces obesity by affecting specific molecules in fat tissue.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Physical activity significantly improved symptoms of PCOS in a patient.

Metformin reduces certain hormone levels in men with early-onset hair loss.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Pro-, pre-, and synbiotics may help with PCOS, but more research is needed.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.